Journal of Clinical Oncology, Vol 12, 608-616, Copyright © 1994 by American Society of Clinical Oncology

ARTICLES

Lessons learned from measuring health-related quality of life in oncology

D Osoba
Division of Medical Oncology, British Columbia Cancer Agency, Vancouver, Canada.

PURPOSE: Measurement of health-related quality of life (HQL) is becoming more common in oncology, particularly in clinical trials. The purpose of this report is to review our progress and assess whether we are learning anything new from these studies. DESIGN: The subject was reviewed by a literature search and selection of available literature in the English language. The results emerged from this review. RESULTS: Six lessons that emerged from measurement of HQL in oncology were chosen for emphasis. These are (1) HQL is a multidimensional construct and should be measured with multidimensional instruments, (2) observers are poor judges of how patients feel about their HQL, (3) it is possible to achieve high rates of compliance in the collection of self- report HQL data, (4) aggressive therapy may result in improved HQL, (5) symptoms are associated with quantifiable disruptions in HQL, and (6) pretreatment HQL may be predictive of on-treatment HQL and of survival. CONCLUSION: None of the six points chosen for emphasis was known with certainty as little as 10 years ago. Although other points for emphasis may be chosen, those emphasized in this review could have a major impact on how we judge success in future clinical trials.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				J.-x. Cheng, X. Zhang, and B.-L. Liu Health-related quality of life in patients with high-grade glioma Neuro-oncol, January 1, 2009; 11(1): 41 - 50. [Abstract] [Full Text] [PDF]

				C. C. Gotay, C. T. Kawamoto, A. Bottomley, and F. Efficace The Prognostic Significance of Patient-Reported Outcomes in Cancer Clinical Trials J. Clin. Oncol., March 10, 2008; 26(8): 1355 - 1363. [Abstract] [Full Text] [PDF]

				F. Joly, J. Vardy, M. Pintilie, and I. F. Tannock Quality of life and/or symptom control in randomized clinical trials for patients with advanced cancer Ann. Onc., December 1, 2007; 18(12): 1935 - 1942. [Abstract] [Full Text] [PDF]

				G. H. Guyatt, C. E. Ferrans, M. Y. Halyard, D. A. Revicki, T. L. Symonds, C. G. Varricchio, A. Kotzeva, J. M. Valderas, J. L. Alonso, and Clinical Significance Consensus Meeting Group Exploration of the Value of Health-Related Quality-of-Life Information From Clinical Research and Into Clinical Practice Mayo Clin. Proc., October 1, 2007; 82(10): 1229 - 1239. [Abstract] [Full Text] [PDF]

				F Efficace, D Osoba, C Gotay, M Sprangers, C Coens, and A Bottomley Has the quality of health-related quality of life reporting in cancer clinical trials improved over time? Towards bridging the gap with clinical decision making Ann. Onc., April 1, 2007; 18(4): 775 - 781. [Abstract] [Full Text] [PDF]

				S. Saigal, B. Stoskopf, J. Pinelli, D. Streiner, L. Hoult, N. Paneth, and J. Goddeeris Self-Perceived Health-Related Quality of Life of Former Extremely Low Birth Weight Infants at Young Adulthood Pediatrics, September 1, 2006; 118(3): 1140 - 1148. [Abstract] [Full Text] [PDF]

				J. Svedlund, M. Sullivan, B. Liedman, and L. Lundell Relationship of Tumor Burden and Patients' Minimization of Distress in Facing Surgery for Gastric Cancer Psychosomatics, June 1, 2005; 46(3): 233 - 243. [Abstract] [Full Text] [PDF]

				G. I. Gorodokin and A. A. Novik Quality of cancer care Ann. Onc., June 1, 2005; 16(6): 991 - 991. [Full Text] [PDF]

				U.-S. Lehto, M. Ojanen, and P. Kellokumpu-Lehtinen Predictors of quality of life in newly diagnosed melanoma and breast cancer patients Ann. Onc., May 1, 2005; 16(5): 805 - 816. [Abstract] [Full Text] [PDF]

				Z. Gil, A. Abergel, S. Spektor, A. Khafif, and D. M. Fliss Patient, Caregiver, and Surgeon Perceptions of Quality of Life Following Anterior Skull Base Surgery Arch Otolaryngol Head Neck Surg, November 1, 2004; 130(11): 1276 - 1281. [Abstract] [Full Text] [PDF]

				F. Efficace, P. Therasse, M. J. Piccart, C. Coens, K. Van Steen, M. Welnicka-Jaskiewicz, T. Cufer, J. Dyczka, M. Lichinitser, L. Shepherd, et al. Health-Related Quality of Life Parameters As Prognostic Factors in a Nonmetastatic Breast Cancer Population: An International Multicenter Study J. Clin. Oncol., August 15, 2004; 22(16): 3381 - 3388. [Abstract] [Full Text] [PDF]

				K. L. Taylor, R. Shelby, E. Gelmann, and C. McGuire Quality of Life and Trial Adherence Among Participants in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial J Natl Cancer Inst, July 21, 2004; 96(14): 1083 - 1094. [Abstract] [Full Text] [PDF]

				A. Bottomley, L. Biganzoli, T. Cufer, R. E. Coleman, C. Coens, F. Efficace, H. A. Calvert, T. Gamucci, C. Twelves, P. Fargeot, et al. Randomized, Controlled Trial Investigating Short-Term Health-Related Quality of Life With Doxorubicin and Paclitaxel Versus Doxorubicin and Cyclophosphamide As First-Line Chemotherapy in Patients With Metastatic Breast Cancer: European Organization for Research and Treatment of Cancer Breast Cancer Group, Investigational Drug Branch for Breast Cancer and the New Drug Development Group Study J. Clin. Oncol., July 1, 2004; 22(13): 2576 - 2586. [Abstract] [Full Text] [PDF]

				P. Rauch, J. Miny, T. Conroy, L. Neyton, and F. Guillemin Quality of Life Among Disease-Free Survivors of Rectal Cancer J. Clin. Oncol., January 15, 2004; 22(2): 354 - 360. [Abstract] [Full Text] [PDF]

				S. Morita, K. Kobayashi, K. Eguchi, T. Matsumoto, M. Shibuya, Y. Yamaji, J. Sakamoto, and Y. Ohashi Influence of Clinical Parameters on Quality of Life During Chemotherapy in Patients with Advanced Non-small Cell Lung Cancer: Application of a General Linear Model Jpn. J. Clin. Oncol., September 1, 2003; 33(9): 470 - 476. [Abstract] [Full Text] [PDF]

				M. J. Fisch, M. L. Titzer, J. L. Kristeller, J. Shen, P. J. Loehrer, S.-H. Jung, S. D. Passik, and L. H. Einhorn Assessment of Quality of Life in Outpatients With Advanced Cancer: The Accuracy of Clinician Estimations and the Relevance of Spiritual Well-Being--A Hoosier Oncology Group Study J. Clin. Oncol., July 15, 2003; 21(14): 2754 - 2759. [Abstract] [Full Text] [PDF]

				D. T. Eton, D. L. Fairclough, D. Cella, S. E. Yount, P. Bonomi, and D. H. Johnson Early Change in Patient-Reported Health During Lung Cancer Chemotherapy Predicts Clinical Outcomes Beyond Those Predicted by Baseline Report: Results From Eastern Cooperative Oncology Group Study 5592 J. Clin. Oncol., April 15, 2003; 21(8): 1536 - 1543. [Abstract] [Full Text] [PDF]

				C. A. Meyers and K. R. Hess Multifaceted end points in brain tumor clinical trials: Cognitive deterioration precedes MRI progression Neuro-oncol, April 1, 2003; 5(2): 89 - 95. [Abstract] [PDF]

				E.P. Wright, P.J. Selby, M. Crawford, A. Gillibrand, C. Johnston, T.J. Perren, R. Rush, A. Smith, G. Velikova, K. Watson, et al. Feasibility and Compliance of Automated Measurement of Quality of Life in Oncology Practice J. Clin. Oncol., January 15, 2003; 21(2): 374 - 382. [Abstract] [Full Text] [PDF]

				S. Kaasa and J. H. Loge Quality of life in palliative care: principles and practice Palliative Medicine, January 1, 2003; 17(1): 11 - 20. [Abstract] [PDF]

				S. Bhatia, M. E.M. Jenney, M. K. Bogue, T. H. Rockwood, J. H. Feusner, D. L. Friedman, L. L. Robison, and R. L. Kane The Minneapolis-Manchester Quality of Life Instrument: Reliability and Validity of the Adolescent Form J. Clin. Oncol., December 15, 2002; 20(24): 4692 - 4698. [Abstract] [Full Text] [PDF]

				M. H. Frost, A. E. Bonomi, C. E. Ferrans, G. Y. Wong, R. D. Hays, and Clinical Significance Consensus Meeting Group Patient, Clinician, and Population Perspectives on Determining the Clinical Significance of Quality-of-Life Scores Mayo Clin. Proc., May 1, 2002; 77(5): 488 - 494. [Abstract] [PDF]

				A. Bottomley The Cancer Patient and Quality of Life Oncologist, April 1, 2002; 7(2): 120 - 125. [Abstract] [Full Text] [PDF]

				F. Cardoso, A. Di Leo, C. Lohrisch, C. Bernard, F. Ferreira, and M. J. Piccart Second and subsequent lines of chemotherapy for metastatic breast cancer: what did we learn in the last two decades? Ann. Onc., February 20, 2002; 13(2): 197 - 207. [Abstract] [Full Text] [PDF]

				J. Sloan Asking the Obvious Questions Regarding Patient Burden J. Clin. Oncol., January 1, 2002; 20(1): 4 - 6. [Full Text] [PDF]

				J. Seidenfeld, M. Piper, C. Flamm, V. Hasselblad, J. O. Armitage, C. L. Bennett, M. S. Gordon, A. E. Lichtin, J. L. Wade III, S. Woolf, et al. Epoetin Treatment of Anemia Associated With Cancer Therapy: a Systematic Review and Meta-analysis of Controlled Clinical Trials J Natl Cancer Inst, August 15, 2001; 93(16): 1204 - 1214. [Abstract] [Full Text] [PDF]

				C. C. Gotay, C. M. Moinpour, S. Moody-Thomas, E. R. Gritz, K. S. Albain, E. DeAntoni, L. Hansen, and P. A. Ganz Behavioral Science Research in the Cooperative Group Setting: the Southwest Oncology Group Experience J Natl Cancer Inst, September 6, 2000; 92(17): 1381 - 1387. [Full Text] [PDF]

				M.-C. Mormont, J. Waterhouse, P. Bleuzen, S. Giacchetti, A. Jami, A. Bogdan, J. Lellouch, J.-L. Misset, Y. Touitou, and F. Lévi Marked 24-h Rest/Activity Rhythms Are Associated with Better Quality of Life, Better Response, and Longer Survival in Patients with Metastatic Colorectal Cancer and Good Performance Status Clin. Cancer Res., August 1, 2000; 6(8): 3038 - 3045. [Abstract] [Full Text]

				C. M. Moinpour, L. C. Lovato, I. M. Thompson Jr, J. E. Ware Jr, P. A. Ganz, D. L. Patrick, S. A. Shumaker, G. W. Donaldson, A. Ryan, and C. A. Coltman Jr Profile of Men Randomized to the Prostate Cancer Prevention Trial: Baseline Health-Related Quality of Life, Urinary and Sexual Functioning, and Health Behaviors J. Clin. Oncol., May 9, 2000; 18(9): 1942 - 1953. [Abstract] [Full Text] [PDF]

				G. Macquart-Moulin, P. Viens, T. Palangie, M.-L. Bouscary, T. Delozier, H. Roche, M. Janvier, M. Fabbro, and J.-P. Moatti High-Dose Sequential Chemotherapy With Recombinant Granulocyte Colony-Stimulating Factor and Repeated Stem-Cell Support for Inflammatory Breast Cancer Patients: Does Impact on Quality of Life Jeopardize Feasibility and Acceptability of Treatment? J. Clin. Oncol., February 14, 2000; 18(4): 754 - 754. [Abstract] [Full Text] [PDF]

				J. L. Stanford, Z. Feng, A. S. Hamilton, F. D. Gilliland, R. A. Stephenson, J. W. Eley, P. C. Albertsen, L. C. Harlan, and A. L. Potosky Urinary and Sexual Function After Radical Prostatectomy for Clinically Localized Prostate Cancer: The Prostate Cancer Outcomes Study JAMA, January 19, 2000; 283(3): 354 - 360. [Abstract] [Full Text] [PDF]

				D. Waldron, C. A. O'Boyle, M. Kearney, M. Moriarty, and D. Carney Quality-of-Life Measurement in Advanced Cancer: Assessing the Individual J. Clin. Oncol., November 1, 1999; 17(11): 3603 - 3611. [Abstract] [Full Text] [PDF]

				A. L. Potosky, L. C. Harlan, J. L. Stanford, F. D. Gilliland, A. S. Hamilton, P. C. Albertsen, J. W. Eley, J. M. Liff, D. Deapen, R. A. Stephenson, et al. Prostate Cancer Practice Patterns and Quality of Life: the Prostate Cancer Outcomes Study J Natl Cancer Inst, October 20, 1999; 91(20): 1719 - 1724. [Full Text] [PDF]

				G. P. Browman Science, Language, Intuition, and the Many Meanings of Quality of Life J. Clin. Oncol., June 1, 1999; 17(6): 1651 - 1651. [Full Text] [PDF]

				G. Velikova, E. P. Wright, A. B. Smith, A. Cull, A. Gould, D. Forman, T. Perren, M. Stead, J. Brown, and P. J. Selby Automated Collection of Quality-of-Life Data: A Comparison of Paper and Computer Touch-Screen Questionnaires J. Clin. Oncol., March 1, 1999; 17(3): 998 - 998. [Abstract] [Full Text] [PDF]

				M. Ersek, B. R. Ferrell, K. H. Dow, and C. H. Melancon Quality of Life in Women with Ovarian Cancer West J Nurs Res, June 1, 1997; 19(3): 334 - 350. [Abstract] [PDF]

				R. J. Ignoffo and R. King Pharmaceutical care and the cancer patient Journal of Oncology Pharmacy Practice, December 1, 1995; 1(4): 7 - 19. [Abstract] [PDF]